[go: up one dir, main page]

WO2003004531A3 - Regulation d'une proteine du type recepteur de la somatostatine humaine - Google Patents

Regulation d'une proteine du type recepteur de la somatostatine humaine Download PDF

Info

Publication number
WO2003004531A3
WO2003004531A3 PCT/EP2002/007564 EP0207564W WO03004531A3 WO 2003004531 A3 WO2003004531 A3 WO 2003004531A3 EP 0207564 W EP0207564 W EP 0207564W WO 03004531 A3 WO03004531 A3 WO 03004531A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
somatostatin receptor
human somatostatin
regulation
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/007564
Other languages
English (en)
Other versions
WO2003004531A2 (fr
Inventor
Shyam Ramakrishnan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of WO2003004531A2 publication Critical patent/WO2003004531A2/fr
Publication of WO2003004531A3 publication Critical patent/WO2003004531A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/655—Somatostatins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des réactifs qui régulent une protéine de type récepteur de la somatostatine humaine, et des réactifs qui se lient avec les produits géniques de type récepteur de la somatostatine humaine. Ces réactifs sont utilisés pour réguler l'effet de la somatostatine, et permettent de traiter les maladies du système nerveux périphérique et central, les maladies hématologiques, l'obésité, le diabète, l'asthme et les cancers.
PCT/EP2002/007564 2001-07-06 2002-07-08 Regulation d'une proteine du type recepteur de la somatostatine humaine Ceased WO2003004531A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2001/007737 WO2003004530A1 (fr) 2001-07-06 2001-07-06 Régulation de la protéine semblable à un récepteur de la somatostatine humaine
EPPCT/EP01/07737 2001-07-06

Publications (2)

Publication Number Publication Date
WO2003004531A2 WO2003004531A2 (fr) 2003-01-16
WO2003004531A3 true WO2003004531A3 (fr) 2003-12-04

Family

ID=8164490

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2001/007737 Ceased WO2003004530A1 (fr) 2001-07-06 2001-07-06 Régulation de la protéine semblable à un récepteur de la somatostatine humaine
PCT/EP2002/007564 Ceased WO2003004531A2 (fr) 2001-07-06 2002-07-08 Regulation d'une proteine du type recepteur de la somatostatine humaine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007737 Ceased WO2003004530A1 (fr) 2001-07-06 2001-07-06 Régulation de la protéine semblable à un récepteur de la somatostatine humaine

Country Status (1)

Country Link
WO (2) WO2003004530A1 (fr)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999037679A1 (fr) * 1998-01-26 1999-07-29 Millennium Pharmaceuticals, Inc. Recepteurs de ligands et leurs utilisations
WO2000064942A1 (fr) * 1999-04-27 2000-11-02 Smithkline Beecham Corporation Axor-27, recepteur couple a une proteine g
WO2001012673A1 (fr) * 1999-08-17 2001-02-22 Merck Patent Gmbh Polypeptides pgpcr-3 et leurs sequences d'adn
WO2001036471A2 (fr) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine
WO2001036473A2 (fr) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Recepteurs couples a une proteine g
WO2001042288A2 (fr) * 1999-12-10 2001-06-14 Incyte Genomics, Inc. Recepteurs couples a la proteine g
WO2001048188A1 (fr) * 1999-12-28 2001-07-05 Helix Research Institute Nouveaux recepteurs couples a la proteine de liaison a guanosine triphosphate, leurs genes, leur preparation et leur utilisation
WO2001068848A2 (fr) * 2000-03-01 2001-09-20 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
WO2001090189A2 (fr) * 2000-05-24 2001-11-29 Akzo Nobel N.V. Gene org3 du recepteur couple a une proteine g

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999037679A1 (fr) * 1998-01-26 1999-07-29 Millennium Pharmaceuticals, Inc. Recepteurs de ligands et leurs utilisations
WO2000064942A1 (fr) * 1999-04-27 2000-11-02 Smithkline Beecham Corporation Axor-27, recepteur couple a une proteine g
WO2001012673A1 (fr) * 1999-08-17 2001-02-22 Merck Patent Gmbh Polypeptides pgpcr-3 et leurs sequences d'adn
WO2001036473A2 (fr) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Recepteurs couples a une proteine g
WO2001036471A2 (fr) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine
WO2001042288A2 (fr) * 1999-12-10 2001-06-14 Incyte Genomics, Inc. Recepteurs couples a la proteine g
WO2001048188A1 (fr) * 1999-12-28 2001-07-05 Helix Research Institute Nouveaux recepteurs couples a la proteine de liaison a guanosine triphosphate, leurs genes, leur preparation et leur utilisation
WO2001068848A2 (fr) * 2000-03-01 2001-09-20 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
WO2001090189A2 (fr) * 2000-05-24 2001-11-29 Akzo Nobel N.V. Gene org3 du recepteur couple a une proteine g

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 200145, Derwent World Patents Index; Class B04, AN 2001-425662, XP002190613 *
LEE D K ET AL: "Discovery and mapping of ten novel G protein-coupled receptor genes", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 275, no. 1, 5 September 2001 (2001-09-05), pages 83 - 91, XP004307114, ISSN: 0378-1119 *

Also Published As

Publication number Publication date
WO2003004531A2 (fr) 2003-01-16
WO2003004530A1 (fr) 2003-01-16

Similar Documents

Publication Publication Date Title
AU2003284891A1 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
WO2003004531A3 (fr) Regulation d'une proteine du type recepteur de la somatostatine humaine
WO2002072824A3 (fr) Regulation du canal potentiel humain du recepteur transitoire humain
WO2002058724A8 (fr) Utilisation de lp82 pour traiter les problemes de poids
WO2004089982A3 (fr) Variantes april et leurs procedes
EP1383875A4 (fr) Nadph oxydase humaine isolee, molecules d'acide nucleique codant lesdites proteines et leurs utilisations
WO2002055694A3 (fr) Polynucleotides et polypeptides de genes metaboliques et leurs utilisations
WO2002036613A3 (fr) Regulation de la proteine humaine de type 'patched'
WO2002062974A3 (fr) Regulation de la proteine humaine elongase hselo1
WO2002088362A3 (fr) Regulation d'une proteine semblable a la prostaglandine-f synthase 1 humaine
WO2002032938A3 (fr) Regulation de la proteine humaine de type pgc-1
WO2002081705A3 (fr) Regulation de la proteine humaine de type acetyltransferase gnat
WO2002046403A3 (fr) Regulation de la proteine humaine du type 'patched'
WO2003025174A3 (fr) Regulation de la proteine humaine de type mrp1
WO2001085766A3 (fr) Sequences
EP1383871A4 (fr) Proteines enzymatiques humaines isolees, molecules d'acides nucleiques codant pour ces proteines, et leurs utilisations
WO2003033708A3 (fr) Regulation de la proteine kinase humaine a serine/threonine
WO2002034920A3 (fr) Regulation de la proteine de type ceruloplasmine humaine
EP1385991A4 (fr) Proteines enzymatiques humaines isolees, molecules d'acide nucleique codant lesdites proteines et utilisations associees
WO2002053749A3 (fr) Regulation de la proteine kinase serine/threonine humaine
WO2003000903A3 (fr) Regulation de serine/threonine proteine kinase humaine de type nek
WO2003033709A3 (fr) Regulation de la proteine kinase serine/threonine humaine
WO2002070678A3 (fr) Regulation de la serine/threonine proteine kinase humaine
WO2002046402A3 (fr) Regulation de la proteine humaine de type 'patched'
WO2002055681A3 (fr) Regulation de la tau-tubuline kinase humaine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP